- Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Catalán-Uribarrena, G., Bilbao-Barandica, G., Pomposo-Gaztelu, I., Undabeitia-Huertas, J., Ruiz de Gopegui-Ruiz, E., Galbarriatu-Gutiérrez, L., Canales-Llantada, M., Aurrecoechea-Obieta, J., Igartua-Azkune, A., Carbayo-Lozano, G. Acta. Neurochir. (Wien) (2012)